Clinicopathological characteristics and treatment outcomes of advanced SMARCA4‐deficient thoracic tumors
Abstract Purpose SMARCA4‐deficient thoracic tumors, characterized by distinct clinicopathological, morphological, immunohistochemical, and genetic features, differ significantly from conventional non‐small‐cell lung carcinomas (NSCLCs). This group encompasses both SMARCA4‐deficient NSCLCs (SMARCA4‐N...
Main Authors: | Anni Wang, Yueping Jin, Zhengqi Cao, Li Lu, Ziming Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.6809 |
Similar Items
-
An aggressive case of a thoracic undifferentiated SMARCA4‐deficient tumor with extensive pleural involvement
by: Paul F. Hanona, et al.
Published: (2024-04-01) -
Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor
by: Ping Zhou, et al.
Published: (2024-02-01) -
A case of thoracic SMARCA4‐Deficient undifferentiated tumor successfully treated with combination Ipilimumab–Nivolumab
by: Yoshio Nakano, et al.
Published: (2022-12-01) -
Thoracic SMARCA4‐deficient undifferentiated tumour: Diagnostic challenges and potential for misdiagnosis in small tissue samples
by: Deborah Johanna Maartens, et al.
Published: (2023-11-01) -
SMARCA4-deficient tumors in the adrenal gland and small intestines: A rare case report
by: Akira Kambe, MD, et al.
Published: (2024-02-01)